Avance Clinical News

  1. Frost & Sullivan Analysis Reveals 65% Of US Biotechs Struggle To Identify Suitable CRO Partner 1/8/2024

    Avance Clinical, the leading Australian and North American CRO for biotechs announced today that new industry analysis shows 60-65% of US biotechs face challenges identifying the right sized CRO partner that can deliver at every phase of their drug development program.